Awards & GrantsCollaborations & Partnerships Boehringer Ingelheim Pharmaceuticals opens call for early-stage innovators pursuing therapeutic research
AwarenessCollaborations & PartnershipsNF1NF2-SWNStory of NF Patients Help FDA Understand Life with NF
Collaborations & PartnershipsNF1Press ReleaseScience & Research SpringWorks Therapeutics Announces FDA Fast Track Designation for PD-0325901 for NF1 Patients
